Table 2.

Correlation between the level of IGF2BP1 and clinical pathological characteristics of patients with PTC.

		N	IGF2BP1	P
Sex	Male	39	24.48 ± 4.42	0.321
	Female	62	24.84 ± 3.81
Age (y)	< 55	38	25.32 ± 4.21	0.597
	≥ 55	63	24.3.2 ± 3.92
T	T1	88	24.95 ± 3.96	0.585
	T2	13	23.01 ± 4.30
N	N0	64	24.95 ± 3.38	0.049
	N1	37	24.27 ± 5.01
BRAFV600E	Mutation	28	24.53 ± 4.98	0.044
	No mutation	73	24.77 ± 3.65
TGAb/TPOAb	Within normal range	49	24.63 ± 3.91	0.883
	Outside normal range	52	24.77 ± 4.19
Focus	1	90	24.70 ± 4.04	0.256
	2	8	24.73 ± 3.85
	3	2	24.60 ± 3.68
	5	1	26.37